Literature DB >> 19262505

MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease.

S Banerjee1, B Oneda, L M Yap, D P Jewell, G L Matters, L R Fitzpatrick, F Seibold, E E Sterchi, T Ahmad, D Lottaz, J S Bond.   

Abstract

The MEP1A gene, located on human chromosome 6p (mouse chromosome 17) in a susceptibility region for inflammatory bowel disease (IBD), encodes the alpha-subunit of metalloproteinase meprin A, which is expressed in the intestinal epithelium. This study shows a genetic association of MEP1A with IBD in a cohort of ulcerative colitis (UC) patients. There were four single-nucleotide polymorphisms in the coding region (P=0.0012-0.04), and one in the 3'-untranslated region (P=2 x 10(-7)) that displayed associations with UC. Moreover, meprin-alpha mRNA was decreased in inflamed mucosa of IBD patients. Meprin-alpha knockout mice exhibited a more severe intestinal injury and inflammation than their wild-type counterparts following oral administration of dextran sulfate sodium. Collectively, the data implicate MEP1A as a UC susceptibility gene and indicate that decreased meprin-alpha expression is associated with intestinal inflammation in IBD patients and in a mouse experimental model of IBD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262505      PMCID: PMC2670347          DOI: 10.1038/mi.2009.3

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  48 in total

1.  Human N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase (human meprin): genomic structure of the alpha and beta subunits.

Authors:  D Hahn; R Illisson; A Metspalu; E E Sterchi
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

Review 3.  Unravelling the pathogenesis of inflammatory bowel disease.

Authors:  R J Xavier; D K Podolsky
Journal:  Nature       Date:  2007-07-26       Impact factor: 49.962

Review 4.  Insights from mouse models of colitis.

Authors:  R Boismenu; Y Chen
Journal:  J Leukoc Biol       Date:  2000-03       Impact factor: 4.962

5.  Linkage of inflammatory bowel disease to human chromosome 6p.

Authors:  J Hampe; S H Shaw; R Saiz; N Leysens; A Lantermann; S Mascheretti; N J Lynch; A J MacPherson; S Bridger; S van Deventer; P Stokkers; P Morin; M M Mirza; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

6.  Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis.

Authors:  Pallavi Garg; Mauricio Rojas; Anupama Ravi; Katrina Bockbrader; Steven Epstein; Matam Vijay-Kumar; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

Review 7.  Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.

Authors:  Raja Atreya; Markus F Neurath
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

8.  Compartmentalised expression of meprin in small intestinal mucosa: enhanced expression in lamina propria in coeliac disease.

Authors:  Daniel Lottaz; Caroline Buri; Giovanni Monteleone; Sandra Rösmann; Thomas T Macdonald; Ian R Sanderson; Erwin E Sterchi
Journal:  Biol Chem       Date:  2007-03       Impact factor: 3.915

9.  Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.

Authors:  B von Lampe; B Barthel; S E Coupland; E O Riecken; S Rosewicz
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

10.  Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation.

Authors:  Sanjita Banerjee; Judith S Bond
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

View more
  35 in total

1.  Balance of meprin A and B in mice affects the progression of experimental inflammatory bowel disease.

Authors:  Sanjita Banerjee; Ge Jin; S Gaylen Bradley; Gail L Matters; Ryan D Gailey; Jacqueline M Crisman; Judith S Bond
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-11       Impact factor: 4.052

Review 2.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

Review 3.  Proteases: History, discovery, and roles in health and disease.

Authors:  Judith S Bond
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

4.  Meprin A impairs epithelial barrier function, enhances monocyte migration, and cleaves the tight junction protein occludin.

Authors:  Jialing Bao; Renee E Yura; Gail L Matters; S Gaylen Bradley; Pan Shi; Fang Tian; Judith S Bond
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-26

Review 5.  Role of meprin metalloproteinases in cytokine processing and inflammation.

Authors:  Christian Herzog; Randy S Haun; Gur P Kaushal
Journal:  Cytokine       Date:  2018-12-20       Impact factor: 3.861

6.  To be there when the picture is being painted.

Authors:  Judith S Bond
Journal:  J Biol Chem       Date:  2020-11-20       Impact factor: 5.157

7.  The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.

Authors:  Nitin Kumar; Pablo Nakagawa; Branislava Janic; Cesar A Romero; Morel E Worou; Sumit R Monu; Edward L Peterson; Jiajiu Shaw; Frederick Valeriote; Elimelda M Ongeri; Jean-Marie V Niyitegeka; Nour-Eddine Rhaleb; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-09

8.  Villin and actin in the mouse kidney brush-border membrane bind to and are degraded by meprins, an interaction that contributes to injury in ischemia-reperfusion.

Authors:  Elimelda Moige Ongeri; Odinaka Anyanwu; W Brian Reeves; Judith S Bond
Journal:  Am J Physiol Renal Physiol       Date:  2011-07-27

9.  A minimal physiologically based pharmacokinetic model to characterize colon TNF suppression and treatment effects of an anti-TNF monoclonal antibody in a mouse inflammatory bowel disease model.

Authors:  Songmao Zheng; Jin Niu; Brian Geist; Damien Fink; Zhenhua Xu; Honghui Zhou; Weirong Wang
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

10.  Let it flow: Morpholino knockdown in zebrafish embryos reveals a pro-angiogenic effect of the metalloprotease meprin alpha2.

Authors:  André Schütte; Jana Hedrich; Walter Stöcker; Christoph Becker-Pauly
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.